Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, covering all aspects of healthcare, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies, and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest

Feb 28, 2017, 07:00 ET Survey: Real-World Evidence Ranked as the Most Influential Data Source Informing Physician's Treatment Decisions

In a survey of 866 U.S. physicians, respondents ranked real-world evidence as the most important data informing treatment decisions, followed by...


Feb 28, 2017, 07:00 ET New Preclinical Data Show Can-Fite's Namodenoson (CF102) Prevents Progression of Liver Fibrosis

Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address...


Feb 28, 2017, 03:00 ET Myoderm Opens Brand New UK Clinical Distribution Facility

Myoderm, a global leader in clinical trial supply, is excited to announce the opening of their new UK headquarters. This clinical storage and...


Feb 27, 2017, 16:38 ET Good News for Kids with Epilepsy

There's good news for kids with epilepsy. While several new drugs have come out in the last several years for adults with epilepsy, making those...


Feb 27, 2017, 16:17 ET Plant-made Hemophilia Therapy Shows Promise, Penn Dental Study Finds

People with hemophilia require regular infusions of clotting factor to prevent them from experiencing uncontrolled bleeding. But a significant...


Feb 27, 2017, 14:27 ET Bahnbrechende Studie: Die Metaanalyse von 28 Studien zeigt, dass die Stretta Therapie die Ergebnisse bei GERD nachhaltig und nennenswert verbessert

Mederi Therapeutics gab heute die Veröffentlichung einer Metaanalyse von 28 Studien bekannt, in denen 2.468 Patienten mit der Stretta Therapie für...


Feb 27, 2017, 14:09 ET Etude historique : la méta-analyse de 28 études montre que la thérapie Stretta utilisée dans le traitement du reflux gastro-œsophagien améliore systématiquement et sensiblement la condition des patients

Mederi Therapeutics a annoncé aujourd'hui la publication d'une méta-analyse de 28 études, représentant 2 468 patients qui ont bénéficié de la...


Feb 27, 2017, 13:45 ET Studio di riferimento: una meta analisi di 28 studi evidenzia che la terapia Stretta per la MRGE (Malattia da reflusso gastroesofageo) migliora in modo costante e significativo i risultati

Mederi Therapeutics ha annunciato oggi la pubblicazione di una meta analisi di 28 studi, che rappresentano 2468 pazienti sottoposti alla Terapia...


Feb 27, 2017, 13:38 ET Un estudio de referencia muestra que la terapia Stretta para GERD mejora los resultados de manera significativa

- Estudio de referencia: El meta-análisis de 28 estudios muestra que la terapia Stretta para GERD mejora los resultados de manera consistente y...


Feb 27, 2017, 13:07 ET Estudo decisivo: meta-análise de 28 estudos demonstra que a terapia Stretta para GERD aprimora de forma consistente e significativa os resultados

A Mederi Therapeutics anunciou hoje a publicação da meta-análise de 28 estudos, representando 2468 pacientes para os quais a terapia Stretta foi...


Feb 27, 2017, 12:39 ET Estudio histórico: Un metaanálisis de 28 estudios muestra que la terapia Stretta para la ERGE mejora los resultados en forma consistente y significativa

Mederi Therapeutics anunció hoy la publicación de un metaanálisis de 28 estudios, que representan 2468 pacientes que recibieron la terapia Stretta...


Feb 27, 2017, 11:25 ET Who's Getting Sunburned? Survey Finds Risk is Greater for Young Adults with Melanin-Rich Skin

Results from a study published in The Journal of the American Osteopathic Association point to an urgent need for sunburn prevention among young...


Feb 27, 2017, 11:05 ET Parkinson's Foundation Invests $500,000 in Community-Driven Clinical Research To Ease Cognition, Sleep and Fatigue in Parkinson's

The Parkinson's Foundation has awarded $500,000 for translational research grants to address critical unmet needs in Parkinson's disease. The...


Feb 27, 2017, 10:20 ET Veracyte Announces Publication of Data Demonstrating Potential for Non-Invasive Nasal Test to Improve Lung Cancer Diagnosis

Veracyte, Inc. (NASDAQ: VCYT), a genomic diagnostics company focused on reducing unnecessary surgeries and healthcare costs by resolving diagnostic...


Feb 27, 2017, 10:05 ET Karmanos Cancer Institute, Wayne State University receive grant to conduct nation's largest study of factors affecting African Americans with cancer

The Karmanos Cancer Institute and Wayne State University School of Medicine will launch the nation's largest study of African American cancer...


Feb 27, 2017, 09:51 ET NoNO Inc Initiates Phase III Study of NA-1 for Acute Ischemic Stroke

A Multicentre, Randomized, Double-blinded, Placebo-controlled, Parallel Group, Single-dose Design to Determine the Efficacy and Safety of...


Feb 27, 2017, 08:46 ET ALK’s ACARIZAX® Data Results in Significant Change to the GINA Asthma Management Strategy: Sublingual Allergy Immunotherapy (SLIT) Recommended as a Treatment Option in Patients With House Dust Mite Allergic Asthma

ALK (ALKB: DC / OMX: ALK B / AKABY / AKBLF) today announced that for the first time, allergy immunotherapy is now recommended as a treatment...


Feb 27, 2017, 08:30 ET Sanofi and Regeneron to Present New Data on Dupixent® (dupilumab) for Moderate-to-Severe Atopic Dermatitis at Upcoming Medical Congresses

Sanofi and Regeneron Pharmaceuticals, Inc. today announced that detailed results from the Phase 3 CHRONOS study will be presented as a...


Feb 27, 2017, 08:30 ET Regeneron and Sanofi to Present New Data on DUPIXENT® (dupilumab) for Moderate-to-Severe Atopic Dermatitis at Upcoming Medical Congresses

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that detailed results from the Phase 3 CHRONOS study will be presented as...


Feb 27, 2017, 08:00 ET Advaxis and SELLAS Announce Licensing Agreement for Development of WT1 Antigen-Targeting Immunotherapy

Advaxis, Inc. (NASDAQ: ADXS) and SELLAS Life Sciences Group, both late-stage biopharmaceutical companies focused on developing cancer...


Feb 27, 2017, 07:11 ET Landmark Study: Meta-Analysis of 28 Studies Shows Stretta Therapy for GERD Consistently and Significantly Improves Outcomes

Mederi Therapeutics today announced the publication of a meta-analysis of 28 studies, representing 2468 patients who received Stretta Therapy to...


Feb 27, 2017, 07:00 ET 78% Stroke Reduction with Newer No-Touch Beating Heart Bypass Surgery, According to Landmark Study

A landmark study led by Prof. Michael P. Vallely, MBBS, PhD, FRACS, of Sydney Heart and Lung Surgeons and the University of Sydney will be...


Feb 27, 2017, 07:00 ET AcelRx Pharmaceuticals' New Drug Application for DSUVIA Accepted for Filing with PDUFA Date of October 12, 2017

AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative...


Feb 27, 2017, 07:00 ET OWC Pharmaceutical Research Corp Receives IRB Approval to Initiate Safety Testing on its Cannabinoid-Infused Cream for Treatment of Psoriasis

OWC Pharmaceutical Research Corp. (OTCQB: OWCP), ("OWC" or the "Company"), an Israeli-based developer of cannabinoid-based therapies targeting a...


Feb 27, 2017, 06:30 ET Clinical Trial Management System Market Worth $2 Billion by 2024: Global Market Insights Inc.

The report "(CTMS) Clinical Trial Management System Market Size By Component (Software, Hardware, Services), By Product (Enterprise Based, Site...